Insulet Corporation to Present at the Canaccord Genuity 33rd Annual Growth Conference

Marketwired

BEDFORD, MA--(Marketwired - Jul 31, 2013) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the Canaccord Genuity 33rd Annual Growth Conference at the InterContinental Boston. Management is scheduled to present an overview of the Company on Thursday, August 15, 2013 at 2:30 p.m. ET.

During this presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of this presentation during the event, please visit: http://investors.insulet.com. A replay of the webcast will be available for 10 days after the initial presentation.

About Insulet Corporation
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor for diabetes products and supplies, delivered through a high touch customer service model. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: http://suited.myomnipod.com. Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: http://www.myomnipod.com.

Contact:

Stephanie Marks for Insulet Corporation
smarks@lazarpartners.com
212-843-0211
View Comments (0)